AstraZeneca

  • Lynparza 2019 report

    Lynparza 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 31 Pages The 5 Key Questions Addressed by this Report:...

  • Movantik 2019 report

    Movantik 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Symbicort 2019 report

    Symbicort 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Tagrisso 2019 report

    Tagrisso 2019 U.S. PROMOTIONAL AUDIT REPORT Published July 2020 • 28 Pages The 5 Key Questions Addressed by this Report:...

  • Bevespi 2018 report

    Bevespi 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 17 Pages The 5 Key Questions Addressed by this Report:...

  • Brilinta 2018 report

    Brilinta 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Bydureon 2018 report

    Bydureon 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Calquence 2018 report

    Calquence 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Farxiga 2018 report

    Farxiga 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Fasenra 2018 report

    Fasenra 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 30 Pages The 5 Key Questions Addressed by this Report:...

  • Faslodex 2018 report

    Faslodex 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 29 Pages The 5 Key Questions Addressed by this Report:...

  • Imfinzi 2018 report

    Imfinzi 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...